Compare SPRY & MEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPRY | MEG |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | United States | United States |
| Employees | N/A | 3500 |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 788.5M | 930.8M |
| IPO Year | 2020 | 2020 |
| Metric | SPRY | MEG |
|---|---|---|
| Price | $9.20 | $22.14 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $40.00 | $35.25 |
| AVG Volume (30 Days) | ★ 1.7M | 266.4K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 93.69 |
| EPS | N/A | ★ N/A |
| Revenue | $84,278,000.00 | ★ $830,538,000.00 |
| Revenue This Year | $87.40 | $5.41 |
| Revenue Next Year | $81.64 | $7.19 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.26 |
| 52 Week Low | $6.66 | $19.38 |
| 52 Week High | $18.63 | $32.00 |
| Indicator | SPRY | MEG |
|---|---|---|
| Relative Strength Index (RSI) | 60.67 | 52.09 |
| Support Level | $7.82 | $20.80 |
| Resistance Level | $9.51 | $23.48 |
| Average True Range (ATR) | 0.61 | 0.79 |
| MACD | 0.14 | 0.13 |
| Stochastic Oscillator | 74.31 | 88.92 |
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.
Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits and permits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, and soil remediation. The company derives maximum revenue from United States.